Multinational Association of Supportive Care in Cancer International Symposium | Conference

Dr. Keefe on the Role of Supportive Care in Personalized Medicine

July 9th 2014

Dorothy M. K. Keefe, MD, FRACP, past president, MASCC, director, SA Cancer Service, professor of cancer medicine, University of Adelaide, Australia, discusses the role of supportive care in personalized medicine.

Dr. Rapoport on Rolapitant for the Prevention of CINV

July 7th 2014

Bernardo L. Rapoport, MD, chief medical oncologist, The Medical Oncology Center of Rosebank, Johannesburg, South Africa, discusses the utility of rolapitant for preventing chemotherapy-induced nausea and vomiting (CINV).

Aprepitant Yields Significant Benefits for the Prevention of CINV in Children

June 28th 2014

Aprepitant is significantly more effective than a comparator placebo-added regimen in preventing CINV in children, with benefits seen across all phases of treatment.

Enobosarm May Prevent Cancer-Induced Muscle Wasting in NSCLC

June 28th 2014

Treatment with enobosarm demonstrated an increase in lean body mass compared with a decline with placebo in patients with non-small cell lung cancer.

Two Phase III Trials Find Rolapitant Effective, Well-Tolerated for Preventing CINV

June 28th 2014

A single oral dose of rolapitant was found to be effective, safe, and long-lasting for the prevention of CINV in patients whose cancer was being treated with either highly or moderately emetogenic chemotherapy.

Single-Dose of Dexamethasone Adequate With Palonosetron for Controlling CINV

June 28th 2014

Palonosetron administered with a single-dose of dexamethasone adequately controlled nausea and vomiting associated with non-anthracycline-based moderately emetogenic chemotherapy when compared with a longer duration of dexamethasone.

Netupitant-Palonosetron Combination Shows Continued Superiority Over Palonosetron for CINV

June 27th 2014

A treatment intended to control chemotherapy-induced nausea and vomiting that combines netupitant and palonosetron demonstrated superior activity in complete response rates over oral palonosetron monotherapy.

Aprepitant- and Metoclopramide-Based Regimens Demonstrate Similar Efficacy in Preventing Delayed Cisplatin-Induced Emesis

June 27th 2014

For the prevention of nausea and vomiting after the first day of cisplatin-based chemotherapy, both aprepitant and metoclopramide when used in combination with dexamethasone were found to be similarly effective.

Declan Walsh, MSc, FACP, FRCP, on the Under-Diagnosis of Malnutrition

June 27th 2014

Declan Walsh, MSc, FACP, FRCP, director, 2014 MASCC/ISOO International Symposium, discusses the under-diagnosis of malnutrition in palliative medicine.

Alex Molasiotis, RN, PhD, on the Management on Breathlessness

June 27th 2014

Alex Molasiotis, RN, PhD, discusses the results of a pilot feasibility study looking at inspiratory muscle training for the management of breathlessness in patients with lung cancer.

Dr. Roila on Aprepitant for the Prevention of Cisplatin-Induced Delayed Emesis

June 27th 2014

Fausto Roila, MD, chair, Medical Oncology Division, S. Maria Hospital, Terni, Italy, discusses an analysis of aprepitant for the prevention of cisplatin-induced delayed emesis.

Dr. Keefe Discusses Links Between Toxicities

June 27th 2014

Dorothy M. K. Keefe, MD, FRACP, past president, MASCC, director, SA Cancer Service, professor of cancer medicine, University of Adelaide, discusses links between toxicities associated with anticancer drugs.

Dr. Raftopoulos on Pulmonary Toxicity With EGFR TKIs

June 26th 2014

Haralambos Raftopoulos, MD, associate professor, Hofstra North Shore-LIJ School of Medicine, discusses pulmonary toxicity with EGFR tyrosine kinase inhibitors (TKIs).

Ã…ge Schultz, DVM, PhD, Discusses the Cost of Supportive Care Medicine

June 26th 2014

Ã…ge Schultz, DVM, PhD, executive director, Multinational Association of Supportive Care in Cancer (MASCC), discusses pain management and the cost of supportive care medicine.

Dr. Kathleen Foley on the Goal for Cancer Pain Management

September 28th 2012

Kathleen M. Foley, MD, from Memorial Sloan-Kettering Cancer Center, on the history and future goals for cancer pain management.

Dr. Foley Addresses the Importance of Palliative Care

July 31st 2012

Dr. Kathleen Foley, from Memorial Sloan-Kettering Cancer Center, Addresses the Importance of Palliative Care

Dr. Hesketh on Developing Guidelines and Protocols

July 25th 2012

Dr. Paul J. Hesketh, from Lahey Clinic Medical Center, on Developing Guidelines and Protocols

Dr. Ewer Discusses Supportive Care

July 24th 2012

Dr. Michael S. Ewer, from The University of Texas MD Anderson Cancer Center, on Supportive Care

Dr. Gralla on Future Advances in CINV Prevention

July 20th 2012

Dr. Richard Gralla, from Quality of Life Research Associates, on Future Advances in chemotherapy-induced nausea and vomiting Prevention

Carrie Stricker on Barriers to Adopting Triple Therapy

July 19th 2012

Carrie Stricker, PhD, RN, from Abramson Cancer Center, on Barriers to Adopting Triple Therapy